34.236.191.0
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Oncology

Study identifies optimal treatment options for advanced hepatocellular carcinoma

A comprehensive study involving 23 randomized controlled trials has shed light on optimal treatment options for advanced hepatocellular carcinoma (HCC). In the first-line treatment, the combination of a PD-1 inhibitor with bevacizumab and the combination of PD-1 inhibitors with TKIs or bevacizumab demonstrated significant efficacy in extending overall survival and...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-